HIV/AIDS in Ontario: Epidemiological Fact Sheet 2009

Similar documents
Understanding the HIV Care Continuum

Estimates of New HIV Infections in the United States

HIV prevention and the wider UK population. What HIV prevention work should be directed towards the general population in the UK?

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care

Georgia HIV/AIDS Surveillance Summary. Data Through December 31, 2010

M I L L I O N S Figure 2.1 Number of people newly infected with HIV

Hepatitis C Infections in Oregon September 2014

HIV Surveillance Update

Methodology Understanding the HIV estimates

WISCONSIN AIDS/HIV PROGRAM NOTES

Q&A on methodology on HIV estimates

HIV Epidemiology in New York State

4/3/2012. Surveillance. Direct Care. Prevention. Quality Management

Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

The HIV/AIDS Epidemic in California s Latino Population

West Virginia HIV/AIDS Surveillance Report 2009 Update West Virginia HIV/AIDS Program

SCIENCE AND TECHNOLOGY AS UGANDA AND THE SEARCH FOR AN AIDS VACCINE

UNAIDS 2013 AIDS by the numbers

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report Sweden

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

A PLAN FOR HOUSING THE FLORIDA CONSORTIUM FOR HIV/AIDS RESEARCH AT THE AIDS INSTITUTE. Background

Maryland HIV Plan

HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

HIV-AIDS: The Public Health Agency of Canada (PHAC) Report

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

HIV/AIDS In the Houston Area

Goal 6. Combat HIV/AIDS, malaria and other diseases

Illustrating HIV/AIDS in the United States

The Basics of Drug Resistance:

Injection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004

HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE

DC Comprehensive HIV Prevention Plan for : Goals and Objectives

HIV/AIDS Prevention and Care

HIV and AIDS in Bangladesh

Mid-year population estimates. Embargoed until: 20 July :30

HIV/AIDS in the Houston Area

Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report

HIV/AIDS Epidemic Status at-a-glance

HIV Continuum of Care Monitoring Framework 2014

Health Alert Communications Communication in Life Sciences

Long Term Socio-Economic Impact of HIV/AIDS on Children and Policy Response in Thailand

Against the Growing Burden of Disease. Kimberly Elmslie Director General, Centre for Chronic Disease Prevention

Canadian Diabetes Association Pre-Budget Submission. to the House of Common Standing Committee on Finance

UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE

Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011

Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform

Annual Surveillance Report 2014 Supplement

2011 STI Annual Report

Update January Quick Start Guide for Spectrum

Department of Epidemiological Surveillance and Intervention

Gonneke Hermanides, MD Izzy Gerstenbluth, MD epidemiologist

The Epidemiology of Hepatitis A, B, and C

Public Knowledge and Attitudes, 2014

Building on Success: A National Strategy to Save Lives

Case Finding for Hepatitis B and Hepatitis C

Dublin Declaration. on Partnership to fight HIV/AIDS in Europe and Central Asia

HIV New Diagnoses, Treatment and Care in the UK 2015 report

New Brunswick Health Indicators

ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN

Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System

Washington, d.c., has among the highest rates of HIV/AIDS in

EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA

GARPR Online Reporting Tool

A Population Based Risk Algorithm for the Development of Type 2 Diabetes: in the United States

USING OPEN AND DISTANCE LEARNING FOR TEACHER PROFESSIONAL DEVELOPMENT IN THE CONTEXT OF EFA AND THE MDG GOALS: CASE OF THE PEDAGOGIC DRUM IN CAMEROON

Chapter 21. What Are HIV and AIDS?

Texas Diabetes Fact Sheet

NATIONAL HIV/A IDS STR ATEGY

A HISTORY OF THE HIV/AIDS EPIDEMIC WITH EMPHASIS ON AFRICA *

Goal 6: Combat HIV/AIDS, Malaria and Other Diseases

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Substance Abuse Treatment Evaluations and Interventions Program

Integrated HIV Prevention and Care Plan Guidance, including the Statewide Coordinated Statement of Need, CY

HIV/AIDS Epidemiology Report

NATIONAL HIV/AIDS STRATEGY for the UNITED STATES: UPDATED TO 2020

50 years THE GAP REPORT 2014

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Drug Situation in Vancouver UHRI. Report prepared by the Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS

TABLE OF CONTENTS 3.0 HIV/AIDS AMONG AFRICAN AND CARIBBEAN DIASPORA COMMUNITIES LIVING IN THE UNITED STATES... 22

World Health Organization

NATIONAL HIV/AIDS STRATEGY IMPLEMENTING THE

Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES

Ministry of Public Health of Belize National Aids Program. Modes of Transmission Model - MOT New HIV infections expected in Belize for 2014

HIV Prevention Needs Assessment for London

The Balm (HIV/AIDS) Ministry

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Borderless Diseases By Sunny Thai

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO

UNAIDS ISSUES BRIEF 2011 A NEW INVESTMENT FRAMEWORK FOR THE GLOBAL HIV RESPONSE

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

Minnesota HIV/AIDS Epidemiologic Profile

DHAPP SENEGAL BACKGROUND. Country Statistics

Statistical release P0302

How To Help The Ghanian Hiv Recipe Cards

Transcription:

HIV/AIDS in Ontario: Epidemiological Fact Sheet 2009 The HIV/AIDS epidemic in Ontario differs from other jurisdictions in Canada and internationally, and it varies from region to region within Ontario as well. Therefore, it is important to use Ontario and/or local epidemiology when describing the impact of HIV/AIDS in your community and/or across the province. In order to understand the nature of the HIV/AIDS epidemic and the direction its taking, we review data on the estimated number of people newly infected with HIV (incidence), and the estimated total number of people living with HIV/AIDS (prevalence). In addition, we review data on the actual number of people who have been diagnosed, as well as HIV testing rates. In Ontario, the majority of people living with HIV/AIDS are gay and bisexual men (see epidemiologic term Men who have Sex with Men (MSM) below), followed by African, Caribbean, and Black Ontarians (see epidemiologic term HIV Endemic below), Aboriginal Peoples and people who use drugs (see epidemiologic term Injection Drug User () below). In Canada, gay and bisexual men also make up the majority of people living with HIV, but are followed by people who use injection drugs; and globally, HIV is largely a heterosexually acquired infection, concentrated in Sub-Saharan Africa, some parts of the Caribbean region and increasingly in Central Asia. In these regions, women make up half of those infected. The Epidemic in Ontario Epidemiological evidence shows that the prevalence of HIV/AIDS or estimated number of people living with HIV/AIDS (PHA) in Ontario continues to grow, from 22,535 PHAs in 2005 to 27,420 in 2009, an increase of 22%. This is due to decreased mortality related to more effective drug therapy and new HIV infections in specific populations. The incidence of HIV/AIDS or estimated number of new HIV infections was 1,535 in 2009, which represents a 4% increase since 2005. The available data indicates that there are five broad populations in Ontario most likely to be living with or at high-risk of HIV infection: gay and bisexual men; African, Caribbean, and Black Ontarians; Aboriginal Peoples; people who use injection drugs; and, women (who are either members of the high-risk populations or engage in HIV risk activities with them). Through other evidence, we know that there are additional populations, not always immediately clear in the above descriptors, who are part of or networked with the above populations and are at heightened risk of HIV infection. These include people who use drugs through means other than injecting, transwomen and transmen, and people who are incarcerated. AIDS Bureau, Ontario Ministry of Health and Long-Term Care Page 1 of 5

Trends in Ontario as of 2009 Population specific analysis of HIV/AIDS data for Ontario shows the following five-year trends in the epidemic: There were an estimated 15,175 gay and bisexual men living with HIV in Ontario in 2009. This represents 55% of people living with HIV in the province. Gay and bisexual men accounted for 45%, or 693, of the 1,535 estimated new HIV infections in 2009. An analysis of the past five years of epidemiologic data suggests that while HIV prevalence continues to rise amongst gay and bisexual men, the number of new infections appears to have levelled at about or just below 700. African, Caribbean, and Black Ontarians, male and female, infected heterosexually accounted for 5,160 or 19% of people living with HIV/AIDS and 28% of new HIV infections, or 431. Over the past five years, both those living with HIV and those newly infected in this population has continued to grow. People who use injection drugs, male and female, accounted for 1,945 or 7% of people living with HIV/AIDS in the province and 88 or 6% of new HIV infections in 2009. The long-term data show a significant decrease in new infections for, while recent data show instability in the number of new HIV infections since 2005. In some regions, account for a larger proportion of new infections compared to the province overall. In Ottawa, account for 9% of new infections, and in the North, they account for 30% of new infections. Men and women infected heterosexually were individuals who did not identify as members of Ontario s high-risk populations. However, research shows that this group consists of those who engage in HIV risk activity with Ontario s high-risk populations. Heterosexual men and women accounted for 4,304 or 16% of people living with HIV/AIDS and 19% of new HIV infections or 284. The number of new infections in this population has been unstable since 2005. Women who are represented in Ontario s high-risk populations or who engage in HIV risk activities with them accounted for 5,079 or 18% of people living with HIV/AIDS in the province and 26% of new infections, or 395. (Note: Data not separated out for women in the charts and tables below.) Ontario data on HIV infections amongst Aboriginal Peoples is incomplete. Data collected on Aboriginal Peoples through Ontario s Laboratory Enhancement Program which obtains race/ethnicity data on approximately 70% of individuals who test HIV positive, shows that for the 2009-2011 period Aboriginal Peoples represented 2.7% or 43 new infections. Men accounted for 26 new infections, and women 17. In most regions of Ontario, statistical modelling of HIV prevalence show higher rates of HIV amongst the Aboriginal Peoples as compared to the general population. AIDS Bureau, Ontario Ministry of Health and Long-Term Care Page 2 of 5

The following charts and tables illustrate the estimates of HIV incidence (number of new infections) and HIV prevalence (number of people living with HIV) for Ontario. Estimated HIV Incidence and Prevalence by Population 2009. Population* HIV incidence % Population* HIV prevalence % MSM 693 45% MSM 15175 55% MSM- 39 3% MSM- 730 3% 88 6% 1945 7% HIV-endemic 431 28% HIV-endemic 5160 19% Heterosexual 284 19% Heterosexual 4304 16% Blood transfusion 0 0% Blood transfusion 106 <1% TOTAL 1,535 100% TOTAL 27,420 100% HIV Incidence MSM 44% Blood transfusion 0% MSM- 3% Heterosexual 19% 6% HIVendemic 28% MSM MSM- HIV-endemic Heterosexual Blood transfusion HIV Prevalence MSM 55% Blood transfusion 0% MSM- 3% Heterosexual 16% 7% HIVendemic 19% MSM MSM- HIV-endemic Heterosexual Blood transfusion *MSM: Men who have Sex with Men; MSM-: MSM-Injection Drug User; : Injection Drug User; HIV-endemic: In Ontario, primarily African and Caribbean countries. Source: Remis RS, Swantee C, Liu J. Report on HIV/AIDS in Ontario 2009. Ontario Ministry of Health and Long-Term Care, June 2009 HIV Diagnoses By the end of 2009, 30,800 people in Ontario had been diagnosed with HIV and 9,990 had died. Based on these numbers, we can calculate that there were 20,810 people living with HIV who had been diagnosed. Since not everyone who has HIV has been tested and diagnosed, we must add the estimated number of undiagnosed to those diagnosed to better understand the scope of the epidemic. Epidemiologists estimate that about 25% or 6,610 HIV infected persons in Ontario have not been diagnosed. Therefore, the estimated number of people living with HIV or prevalence of HIV in Ontario was 27,420 in 2009. HIV Testing 425,366 people in Ontario were tested for HIV in 2009 (this does not include prenatal HIV testing, see below). Women accounted for 55% of people who tested in that year. Overall, HIV testing rates have been trending upwards by almost 10% since 2005. Gay AIDS Bureau, Ontario Ministry of Health and Long-Term Care Page 3 of 5

and bisexual men, along with African, Caribbean and Black Ontarians experienced a 13% increase in testing rates, and heterosexuals experienced an 11% increase in testing rates since 2005. Prenatal HIV Testing 147,995 women tested for HIV through Ontario s prenatal HIV testing program. The program has been successful at promoting the offer of an HIV test to all pregnant women. HIV testing rates among pregnant women have increased from 33% in 1999 to at least 95% in 2009. It is estimated that mother-to-infant transmissions have been reduced from an estimated 10 a year in 1992 through 1995 to about 2 a year in 2005 through 2009. Mortality Rate Decreases People are living with HIV longer. Since the introduction of anti-retroviral therapies in 1996, the number of HIV-related deaths has decreased by over 50%. As of 2009, an estimated 9,993 people with HIV/AIDS have died since the onset of the epidemic. ----------------------------------------------------- Definitions Epidemiology The science of understanding diseases and their progression. Epidemiologic data helps in understanding the nature and direction of an epidemic (i.e. who is most affected) and assists in determining whether prevention efforts are working. Epidemic The term is used when there are a greater number of cases of a disease than would normally be expected to occur. The HIV/AIDS epidemic in Ontario disproportionately affects specific populations considered to be at high-risk of HIV infection and include gay and bisexual men, African, Caribbean, and Black Ontarians, Aboriginal Peoples, people who use injection drugs, and women at greatest risk. Incidence The estimated number of new infections in a given year. Scientific estimates are used to obtain this number and it is important in understanding whether prevention efforts are working. A decrease in new infections suggests successful interventions. Prevalence The estimated total number of people living with HIV/AIDS, including those diagnosed and those who have not yet been diagnosed. Prevalence helps to understand the overall burden of disease in a community or population. Diagnosis The actual number of people diagnosed with HIV/AIDS. This data is obtained from the number of HIV positive test results. Diagnosis helps in the estimation of the number of new infections and the number of people living with HIV/AIDS. This information also helps in determining the effectiveness of HIV testing initiatives. AIDS Bureau, Ontario Ministry of Health and Long-Term Care Page 4 of 5

Epidemiologic HIV Risk Categories: For identification, tracking and data analysis purposes, epidemiologists have developed the following HIV risk classification categories: MSM: Men who have Sex with Men Identifies Gay, bisexual, and other men who have sex with men. MSM-: MSM-Injection Drug User Identifies Gay, bisexual, and other men who have sex with men, and who are also people who use injection drugs. : Injection Drug User Identifies people who use injection drugs and includes men and women. HIV-endemic Refers to people from countries where the prevalence of HIV/AIDS is considered to be high at 1% or more of the general population. In Ontario, this category refers to people primarily from African and Caribbean HIV endemic countries. Heterosexual Includes heterosexual men and women who are at high-risk and at low-risk of acquiring HIV. High-risk heterosexual refers to person who has reported engaging in HIV sexual risk activity with someone from Ontario s high-risk populations, but does not identify as a member of one of the populations. Low-risk heterosexual refers to a person who is not a member of Ontario s high-risk populations, and has not reported any sexual contact with Ontario s high-risk groups. Research on the Low-risk heterosexual population often shows HIV sexual risk-taking activity with a person from a high-risk group has. References Remis RS, Swantee C, Liu J. Report on HIV/AIDS in Ontario 2009. Ontario Ministry of Health and Long-Term Care. June 2012. Ontario HIV/AIDS epidemiology can be found at the Ontario Epidemiologic Monitoring Unit located at the University of Toronto. Visit their website at: http://www.ohemu.utoronto.ca/ AIDS Bureau, Ontario Ministry of Health and Long-Term Care Page 5 of 5